ipaclr

Annals of Clinical and Laboratory Research

ISSN - 2386-5180

Case Report - (2015) Volume 3, Issue 3

View PDF Download PDF

SLE and Type 1 Diabetes Mellitus Leading to End Stage Renal Disease: A Case Report and Review of the Literature

 

Author info »

Abstract

Objective: Type I diabetes (T1D) and Systemic lupus erythematosus (SLE) are two autoimmune conditions. When occurring in the same patient, they can lead to deleterious end points if not managed aggressively and adequately. The aim of this report is to alert physicians on the seriousness of this combination by presenting the case of a patient with end stage renal disease secondary to T1D and SLE.

Methods: We present the case of a 32 year-old lady with long standing uncontrolled diabetes and 3 years history of SLE, who presented recurrently to our institution with her last admission for preparation for hemodialysis.

Results: Patient had progressive proteinuria and declining GFR since 2012 (first admission). Kidney biopsy was done twice (3 years apart) showing a mixture of lupus nephritis and diabetic nephropathy.

Conclusion: T1D and SLE share common immunological and molecular basis that can aggravate each other leading to important vascular end points.

References

  1. Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51: 3353-3361.
  2. Knip M, Siljander H (2008) Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7: 550-557.
  3. Morran MP, Vonberg A, Khadra A, Pietropaolo M3 (2015) Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med 42: 42-60.
  4. Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, et al. (2011) International Consortium on the Genetics of Systemic Erythematosus. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 7: e1002406.
  5. Mirabelli G, Cannarile F, Bruni C, Vagelli R, De Luca R, et al. (2015) One year in review 2015: systemic lupus erythematosus. Clin Exp Rheumatol 33: 414-425.
  6. Jaberi-Douraki M, Schnell S, Pietropaolo M, Khadra A4 (2015) Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes. J Theor Biol 375: 77-87.
  7. Pietropaolo M, Eisenbarth GS (2001) Autoantibodies in human diabetes. Curr Dir Autoimmun 4: 252-282.
  8. Chambers SA, Charman SC, Rahman A, Isenberg DA (2007) Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Ann Rheum Dis 66: 1173-1177.
  9. Buyon, J, Wallace, DJ (2002) The use of exogenous estrogens, endocrine system and urogenital tract. In: Wallace DJ, Hahn BH (6th edn), Dubois’ Lupus Erythematosus. Philadelphia: Lippincott, Williams & Wilkins 821–841.
  10. Kota SK, Meher LK, Jammula S, Kota SK, Modi KD (2012) Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metab Syndr 6: 70-76.
  11. Cortes S, Chambers S, Jerónimo A, Isenberg D (2008) Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature. Lupus 17: 977-980.
  12. Heras P, Mantzioros M, Mendrinos D, Heras V, Hatzopoulos A, et al. (2010) Autoantibodies in type 1 diabetes. Diabetes Res Clin Pract 90: e40-42.
  13. Harrop M, Caudwell J, Stojanovski C, Colman PG (1992) Insulin autoantibodies in patients with autoimmune diseases. Diabetes Res Clin Pract 18: 107-112.
  14. Mariño E, Grey ST (2012) B cells as effectors and regulators of autoimmunity. Autoimmunity 45: 377-387.
  15. Pottathil R, Huang SW, Chandrabose KA (1985) Essential fatty acids in diabetes and systemic lupus erythematosus (SLE) patients. Biochem Biophys Res Commun 128: 803-808.
  16. Koenig KF, Ribi C, Radosavac M, Zulewski H, Trendelenburg M3; Swiss SLE cohort study (SSCS) (2015) Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. Lupus 24: 58-65.

Author Info

 

, DOI: 10.21767/2386-5180.100028

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

iomcworld scan

Journal Highlights

Journal Flyer

Flyer

+447482874092